Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study of Daclizumab in Patients With Chronic, Persistent Asthma

ClinicalTrials.gov ID: NCT00028288

Public ClinicalTrials.gov record NCT00028288. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 4:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Daclizumab in Patients With Chronic, Persistent Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to evaluate an investigational medication to treat chronic persistent asthma. The research is being conducted at up to 22 clinical research sites in the US and is open to both men and women ages 18 to 70 years old. Participants in the study will have a number of visits to a research site over a 10-month period. All study-related care and medication is provided to qualified participants at no cost: this includes all visits, examinations and laboratory work.

Study identification

NCT ID
NCT00028288
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Facet Biotech
Industry
Enrollment
120 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2001
Primary completion
Nov 30, 2003
Completion
Nov 30, 2003
Last update posted
Mar 12, 2012

2001 – 2003

United States locations

U.S. sites
18
U.S. states
12
U.S. cities
17
Facility City State ZIP Site status
Medical Research Associates Long Beach California 90806
Southern California Research Mission Viejo California 92691
Institute of Health Care Assessment, Inc. San Diego California 92120
Bensch Research Associates Stockton California 95207
National Jewish Medical and Research Center Denver Colorado 80206
Clinical Reserch Centers of Colorado Denver Colorado 80230
Florida Center for Allergy and Asthma Reserch Miami Florida 33176
Rx Research Woodstock Georgia 30188
ICSL Clinical Studies Bloomington Illinois 61704
Asthma and Allergy Center of Chicago, S.C. River Forest Illinois 60305
New England Clinical Studies North Dartmouth Massachusetts 02747
Clinical Research Institute Minneapolis Minnesota 55402
Princeton Center for Clinical Research Princeton New Jersey 08540
Allergy, Asthma, and Dermatology Research Center, LLC Lake Oswego Oregon 97035
Valley Clinical Research Center Easton Pennsylvania 18045
Pharmaceutical Research and Consulting, Inc. Dallas Texas 75231
University of Wisconsin Medical School Madison Wisconsin 53792
Allergy and Respiratory Care Center Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00028288, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 12, 2012 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00028288 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →